ADA releases 2018 medical care standards for diabetes | Research examines efficacy of SGLT2 inhibitors, pioglitazone in reducing A1C | Study compares safety of injected, oral medications for gestational diabetes
December 11, 2017
DiabetesPro SmartBrief
News for diabetes health professionals
SIGN UP ⋅   FORWARD
Diabetes in Focus
ADA releases 2018 medical care standards for diabetes
Type 2 diabetes patients with established atherosclerotic cardiovascular disease who don't meet glycemic targets with metformin and lifestyle modification should be given a glucose-lowering drug with proven cardiovascular benefit and/or mortality reduction, such as liraglutide or empagliflozin, according to the American Diabetes Association's 2018 guidelines published in Diabetes Care. "The standards of care are the primary resource for the optimal management of diabetes and include updated guidelines for diabetes diagnosis and for evidence-based prevention of diabetes and diabetes-related complications," said William Cefalu, ADA's chief scientific, medical and mission officer. He also said ADA plans to update the standards continually, as needed.
Medscape (free registration) (12/8) 
LinkedIn Twitter Facebook Google+ Email
Research examines efficacy of SGLT2 inhibitors, pioglitazone in reducing A1C
A study in the Journal of Diabetes Investigation showed that type 2 diabetes patients who received pioglitazone or SGLT2 inhibitors as add-ons to insulin therapy had a greater A1C reduction than those on placebo. Korean researchers conducted a meta-analysis of randomized controlled trials involving 7,226 patients and found that those in the SGLT2 inhibitor and pioglitazone groups also showed reduced fasting plasma glucose levels and insulin dose requirements, compared with the placebo groups.
Healio (free registration)/Endocrine Today (12/8) 
LinkedIn Twitter Facebook Google+ Email
Study compares safety of injected, oral medications for gestational diabetes
Researchers evaluated 99 studies involving 13,816 pregnant women with gestational diabetes and infants born to mothers who had GD and found no differences in the risk for infant mortality, infant hypoglycemia or childhood adiposity at 18 months between women who received insulin injections or oral medications. The findings in Cochrane Database of Systematic Reviews also revealed no difference in the risk for type 2 diabetes development, preeclampsia or birth by cesarean section between those who received insulin and oral medications.
Endocrinology Advisor (12/8) 
LinkedIn Twitter Facebook Google+ Email
Nutrition & Wellness
Study: Children's movies promote unhealthy food choices
A study in Pediatrics that analyzed 31 G- and PG-rated movies from 2012 through to 2015 found they all promoted obesity or unhealthy food or beverage choices at least one time, and most had the themes throughout the film. Healthy foods often were linked to negative or neutral emotions, less nutritious foods were more likely to be cast in a positive way, and overweight and obese characters were depicted negatively.
Medical News Today (12/7) 
LinkedIn Twitter Facebook Google+ Email
Study: Fruit, veggie consumption up under farm-to-school programs
Farm-to-school programs have boosted the number of students consuming fruits and vegetables, according to a study in the Journal of Nutrition Education and Behavior. Data show students at schools with such programs consume 37% more vegetables and 11% more fruit than before adoption of the program.
The Packer (Lenexa, Kan.) (12/5) 
LinkedIn Twitter Facebook Google+ Email
Practice Update
4 health organizations to pilot OurNotes initiative
4 health organizations to pilot OurNotes initiative
(Allison Joyce/Getty Images)
A pilot program for OurNotes, an initiative targeting patient-provider collaboration in writing clinical notes and care plans within a shared EHR, will begin in the spring at Beth Israel Deaconess Medical Center, the University of Colorado, the University of Washington and Dartmouth-Hitchcock Medical Center. Beth Israel, which uses its own EHR system, will aid in organizing and standardizing efforts with the other sites, which use Epic systems, said Dr. Matthew Germak of Beth Israel.
Health Data Management (free registration) (12/5) 
LinkedIn Twitter Facebook Google+ Email
 
Hot Topics
Trends & Technology
ACA automatic enrollment could cause problems for some people
People who have health insurance under the Affordable Care Act and don't re-enroll by the Dec. 15 deadline will be automatically enrolled in the same plan or a similar one. Experts say that could leave people with a more costly plan they don't want, and they might not have a chance to change it as they have in the past.
Kaiser Health News (12/8) 
LinkedIn Twitter Facebook Google+ Email
Health care systems approaching AI with caution, focusing on proven tech
Hospital and health system executives responding to a survey said they are interested in artificial intelligence, machine learning and other emerging technology, but they are not rushing to implement it. Instead, they want to improve current EHR systems, standardize IT platforms and strengthen cybersecurity protocols.
Healthcare Informatics online (12/7) 
LinkedIn Twitter Facebook Google+ Email
  
  
Honor is self-esteem made visible in action.
Ayn Rand,
writer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about DiabetesPro:
DiabetesPro Home | Professional Education | Journals
Research Grants | Recognition Programs | Membership
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information